Viewing Study NCT05785468


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2026-01-01 @ 3:23 PM
Study NCT ID: NCT05785468
Status: UNKNOWN
Last Update Posted: 2023-03-27
First Post: 2023-02-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 4305
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators